Drug
Topotecan
Topotecan: highest development phase Approved, developed by GlaxoSmithKline, Sandoz, United Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- GlaxoSmithKline, Sandoz, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| HYCAMTIN | Approved | |
| Topotecan NCT01683149 | Phase 1 | Solid Tumor |
| topotecan NCT00361803 | Phase 1 | Cancer |
Latest
No recent events.
Follow Topotecan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.